Grisnilimab, CAS [[2367001-70-3]]

Produktübersicht

• Artikelname: Grisnilimab, CAS [[2367001-70-3]]
• Artikelnummer: MCE-HY-P99650
• Hersteller Artikelnummer: HY-P99650
• Alternativnummer: MCE-HY-P99650-1MG,MCE-HY-P99650-10MG,MCE-HY-P99650-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: WT1

Produktbeschreibung

Grisnilimab (WT1) is an IgG2a monoclonal antibody targeting CD7. Grisnilimab only binds to lymphoid tissues and T lymphocytes, with no off-target binding to normal tissues. Grisnilimab can be used to synthesize the immunotoxin WT1-SMPT-dgRTA, which exerts cytotoxic effects on T-lymphoblastic leukemia cells. Grisnilimab is applicable to relevant research on leukemia[1].

Produkteigenschaften

• Molekulargewicht: (146.39 kDa)
• Reinheit: 99.43
• CAS Nummer: [2367001-70-3]
• Target-Kategorie: Transmembrane Glycoprotein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies